Management of Age-related Macular Degeneration

Journal of the Indian Medical Association

Volumn 101, Issue 8, 2003, Pages 471-476

  Mohan, K Chandra ^a   Shukla, Dhananjay ^a   Namperumalsamy, P ^a   Kim, R ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

Age related macular degeneration; Anti oxidants; Laser photocoagulation; Photodynamic therapy; Submacular surgery

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COPPER; INTERFERON; STEROID; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN ANTIBODY; ZINC;

BLINDNESS; DISEASE COURSE; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; LIFE EXPECTANCY; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA SURGERY; REVIEW; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

EID: 0347418100     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Klein R, Klein BE, Linton KL - Prevalence of age-related maculopathy: The Beaver Dam Study. Ophthalmology 1992; 99: 933-43.
2. Narendran V, Thulasiraj RD, Kim R, Selvaraj, Katz J, Robin AR, et al - The prevalence of age-related maculopathy in South India. Invest Ophthalmol Vis Sci 2000; 41: S119.
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al - An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International Arm Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-74.
4. Macular Photocoagulation Study Group - Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trials. Arch Ophthalmol 1986; 104: 694-701.
5. Fruend KB, Yannuzzi LA, Sorensen JA - Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993; 115: 786-91.
6. Macular Photocoagulation Study Group - Recurrent choroidal neovascularization after Argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986; 104: 503-12.
7. Macular Photocoagulation Study Group - Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991; 109: 1242-57.
8. Sanislo SR, Lewis H - Submacular hemorrhage. In: Quiroz-Mercado H, Alfaro DV III, Liggett PE, Tano Y, Juan E Jr, editors. Macular Surgery. 1st ed. Philadelphia: Lippincott, 2000: 275-81.
9. Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H, et al - Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol 2002; 133: 215-25.
10. Reichel E, Berrocal AM, Michael IP, Kroll AJ, Desai V, Duker JS, et al - Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999; 106: 1908-14.
11. Chang NHV, Bird AC - Perspective: alternative therapies in exudative age-related macular degeneration. Br J Ophthalmol 1998; 82: 1441-3.
12. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group - Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001; 119: 198-207.
13. Lim JI - Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials. Ophthalmol Clin North Am 2002; 15: 473-8.
14. Archer DB, Amoaku WMK, Gardiner TA - Radiation retinopathy, clinical, histological and ultrastructural correlation. Eye 1991; 5: 239-51.
15. Folkman J, Ingher DE - Angiostatic steroids: method of discovery and mechanism of action. Ann Surg 1987; 206: 374-83.
16. Ciulla TA, Criswels MH, Danis RP, Hills TE - Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser treated rat model. Arch Ophthalmol 2001; 119: 399-404.
17. Danis RP, Cuilla TA, Pratt LM, Anliker W - Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20: 244-50.
18. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP - Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 1996; 114: 964-70.
19. Wells JA, Murthy R, Chibber R, Nunn A, Molinatti PA, Kohner EM, Gregor ZJ - Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularization. Br J Ophthalmol 1996; 80: 363-6.
20. Kvanta A, Algvere PV, Berglin L, Seregard S - Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996; 37: 1929-34.
21. Ciardella AP, Donsoff IM, Guyer DR, Admis A, Yannuzzi LA - Antiangiogenesis agents. Ophthalmol Clin North Am 2002; 15: 453-8.
22. Pharamacological Therapy for Macular Degeneration Study Group - Interferon alpha-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115: 865-72.
23. Blanks JC - Gene therapy for photoreceptor degeneration. In: Quiroz-Mercado H, Alfaro DV III, Liggett PE, Tano Y, Juan ED Jr, editors. Macular Surgery. 1st ed. Philadelphia: Lippincott, 2000:260-74.
24. Age Related Eye Diseases Study Group - A randomized placebo-controlled clinical trial of high-dose supplementation with vitamin C and E, beta carotene and zinc for age-related macular degeneration and vision loss: AREDS Report 8. Arch Ophthalmol 2001; 119: 1417-36.
25. Figueroa MA, Regueras A, Bertand J - Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 1994; 14: 391-406.
26. Choroidal Neovascularization Prevention Trial Research Group - Laser treatment in eyes with large drusen. Ophthalmology 1998; 105: 11-23.